Harvard Will Stop Requiring Covid-19 Testing by May 10
Harvard will phase out its Covid-19 testing requirements over the next three weeks, the school announced Monday, marking the end of one of its last remaining on-campus pandemic precautions.
Students Delay Getting Covid-19 Booster Shots, Citing Inconvenience and Finals
Some Harvard students said they are holding out to get a Covid-19 booster shot until the conclusion of the fall semester, though public health experts recommend people get the shot as soon as possible.
Community Groups Promote Vaccine Awareness Among Cambridge Residents of Color
Cambridge has reported vaccination rates for residents of color that defy national trends: as of Nov. 18, 74 percent of Black residents and 59 percent of Latinx residents are fully vaccinated, while only 33 percent of Black people and 36 percent of Latinx people are fully vaccinated nationwide.
Harvard Likely to Loosen Campus Covid Restrictions in the Spring, Garber Says
As its first in-person semester in over a year winds down, Harvard is preparing to loosen its on-campus Covid-19 restrictions, which include mask requirements and limits on gatherings.
Harvard Lowers Undergrad Testing Frequency Following Decrease in Covid Cases
Harvard decreased the testing cadence for vaccinated affiliates in undergraduate housing on Monday in response to a decrease in positive Covid-19 tests among undergraduate students.
Following Uptick in Campus Respiratory Illnesses, Students Criticize Dorm Ventilation
Students in some of Harvard’s undergraduate dorms are pointing to issues with building ventilation systems as the cause for a surge of respiratory illness cases on campus last month.
NIH Director Monica Bertagnolli Talks Rebuilding Public Health Trust Post-Covid
Former Harvard Medical School professor Monica M. Bertagnolli spoke about the need to restore trust in public health after beginning as National Institutes of Health director in November.
Harvard Medical School-Affiliated Researchers Find One in Five on Paxlovid Experience Covid-19 Rebound
Harvard Medical School-affiliated researchers published research on Nov. 14 showing that one in five patients who used the antiviral drug Paxlovid experienced a rebound case of Covid-19, compared to 2 percent of patients who did not use the drug.
Political Scientist Zach Parolin Talks Poverty Measurement in the 2024 Census at Harvard School of Public Health Talk
Political scientist Zach Parolin announced that the 2024 Census will implement a monthly, “close to real-time” poverty measurement using a methodology he developed during the Covid-19 pandemic at a Harvard Center for Population and Development Studies talk Thursday afternoon.
Former CDC Director Rochelle Walensky Discusses Interplay of Public Health and Politics at IOP Forum
Rochelle P. Walensky, the 19th director of the Centers for Disease Control and Prevention, discussed her tenure at the center throughout the Covid-19 pandemic while facing political strife amid the urgent public health crisis, during a Harvard Institute of Politics forum Wednesday evening.
Harvard Students Report Surge in Covid-19 Cases with Fall Semester Underway
Most freshmen arrive at Harvard College eager to participate in orientation activities, from wilderness hikes to leadership training. But this fall, some spent their first few days on campus in isolation amid a spike in Covid-19 infections.
As Bacow Departs, Political Tensions that Defined His Presidency Endure
During Harvard President Lawrence S. Bacow’s five years in office, he encountered a unique convergence of challenges — one that reflected a higher education landscape under attack. Woven through all this was the pandemic, a crisis during which Bacow was forced to make consequential decisions without a blueprint.
Following Uptick in Campus Respiratory Illnesses, Students Criticize Dorm Ventilation
Students in some of Harvard’s undergraduate dorms are pointing to issues with building ventilation systems as the cause for a surge of respiratory illness cases on campus last month.
NIH Director Monica Bertagnolli Talks Rebuilding Public Health Trust Post-Covid
Former Harvard Medical School professor Monica M. Bertagnolli spoke about the need to restore trust in public health after beginning as National Institutes of Health director in November.
Harvard Medical School-Affiliated Researchers Find One in Five on Paxlovid Experience Covid-19 Rebound
Harvard Medical School-affiliated researchers published research on Nov. 14 showing that one in five patients who used the antiviral drug Paxlovid experienced a rebound case of Covid-19, compared to 2 percent of patients who did not use the drug.
Political Scientist Zach Parolin Talks Poverty Measurement in the 2024 Census at Harvard School of Public Health Talk
Political scientist Zach Parolin announced that the 2024 Census will implement a monthly, “close to real-time” poverty measurement using a methodology he developed during the Covid-19 pandemic at a Harvard Center for Population and Development Studies talk Thursday afternoon.
Former CDC Director Rochelle Walensky Discusses Interplay of Public Health and Politics at IOP Forum
Rochelle P. Walensky, the 19th director of the Centers for Disease Control and Prevention, discussed her tenure at the center throughout the Covid-19 pandemic while facing political strife amid the urgent public health crisis, during a Harvard Institute of Politics forum Wednesday evening.
Harvard Students Report Surge in Covid-19 Cases with Fall Semester Underway
Most freshmen arrive at Harvard College eager to participate in orientation activities, from wilderness hikes to leadership training. But this fall, some spent their first few days on campus in isolation amid a spike in Covid-19 infections.
As Bacow Departs, Political Tensions that Defined His Presidency Endure
During Harvard President Lawrence S. Bacow’s five years in office, he encountered a unique convergence of challenges — one that reflected a higher education landscape under attack. Woven through all this was the pandemic, a crisis during which Bacow was forced to make consequential decisions without a blueprint.